Alzheimer's disease: Current progress, future promise

Patient Care

Volumn 32, Issue 9, 1998, Pages 156-176

  Folstein, Marshal F ^a   Schneider, Lon S ^b   Small, Gary W ^e   Williams, T Franklin ^c,d  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006313222     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Carr DB, Goate A, Phil D, et al: Current concepts in the pathogenesis of Alzheimer's disease. An J Med 1997;103(3A):3S-10S.
2. Costa PT Jr, Williams TF, Somerfield M, et al: Recognition and Initial Assessment of Alzheimer's Disease and Related Dementias. Clinical Practice Guideline No. 19. Rockville, Md: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 97-0702, November 1996.
3. Small GW, Rabins PV, Barry PP, et al: Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363-1371.
4. Rogers SL, Farlow MR, Doody RS, et al: A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998;50:136-145.
5. Knopman D, Schneider L, Davis K, et al: Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality. Neurology 1996;47:166-177.
6. Knopman DS, Morris JC: An update on primary drug therapies for Alzheimer disease. Arch Neurol 1997;54:1406-1409.
7. Sano M, Ernesto C, Thomas RG, et al: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997; 336:1216-1222.
8. Drachman DA, Leber P: Treatment of Alzheimer's disease: Searching for a breakthrough, settling for less, editorial. N Engl J Med 1997;336:1245-1247.
9. Birge SJ, Mortel KF: Estrogen and the treatment of Alzheimer's disease. Am J Med 1997;103(3A):36S-45S.
10. Tang M-X, Jacobs D, Stern Y, et al: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
11. Kawas C, Resnick S, Morrison A, et al: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
12. Schneider LS, Farlow MR, Henderson VW, et al: Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neu-rology 1996;46:1580-1584.
13. Stewart WF, Kawas C, Corrada M, et al: Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48:626-632.